1. Home
  2. KYMR vs DNOW Comparison

KYMR vs DNOW Comparison

Compare KYMR & DNOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • DNOW
  • Stock Information
  • Founded
  • KYMR 2015
  • DNOW 1862
  • Country
  • KYMR United States
  • DNOW United States
  • Employees
  • KYMR N/A
  • DNOW N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • DNOW Metal Fabrications
  • Sector
  • KYMR Health Care
  • DNOW Industrials
  • Exchange
  • KYMR Nasdaq
  • DNOW Nasdaq
  • Market Cap
  • KYMR 1.8B
  • DNOW 1.8B
  • IPO Year
  • KYMR 2020
  • DNOW N/A
  • Fundamental
  • Price
  • KYMR $45.87
  • DNOW $15.21
  • Analyst Decision
  • KYMR Strong Buy
  • DNOW Buy
  • Analyst Count
  • KYMR 16
  • DNOW 2
  • Target Price
  • KYMR $59.38
  • DNOW $17.50
  • AVG Volume (30 Days)
  • KYMR 1.1M
  • DNOW 646.9K
  • Earning Date
  • KYMR 08-06-2025
  • DNOW 08-06-2025
  • Dividend Yield
  • KYMR N/A
  • DNOW N/A
  • EPS Growth
  • KYMR N/A
  • DNOW N/A
  • EPS
  • KYMR N/A
  • DNOW 0.75
  • Revenue
  • KYMR $58,885,000.00
  • DNOW $2,409,000,000.00
  • Revenue This Year
  • KYMR $43.38
  • DNOW $4.72
  • Revenue Next Year
  • KYMR $10.97
  • DNOW $4.27
  • P/E Ratio
  • KYMR N/A
  • DNOW $20.11
  • Revenue Growth
  • KYMR N/A
  • DNOW 4.74
  • 52 Week Low
  • KYMR $19.45
  • DNOW $11.42
  • 52 Week High
  • KYMR $53.27
  • DNOW $18.45
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 67.58
  • DNOW 52.93
  • Support Level
  • KYMR $45.80
  • DNOW $14.78
  • Resistance Level
  • KYMR $47.51
  • DNOW $15.70
  • Average True Range (ATR)
  • KYMR 2.86
  • DNOW 0.34
  • MACD
  • KYMR -0.03
  • DNOW 0.09
  • Stochastic Oscillator
  • KYMR 67.19
  • DNOW 65.62

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

Share on Social Networks: